INS and Hypoglycemia: Taken together, these results highlightedthat administration of oral casNP/insulin/C10 not onlyenhances insulin bioavailability and hepatic targeting but also offersa reduced risk of hypoglycemia by adapting insulin release in responseto the metabolic demand in diabetic mice.